Tolerance Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Tolerance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Quality of Life (QOL)Exercise TherapyAnxiety Depression+7 more
Insel Gruppe AG, University Hospital Bern160 enrolled5 locationsNCT07143539
Recruiting
Not Applicable

Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes

Diabetes Mellitus, Type 2Continuous Glucose MonitoringFecal Microbiota Transplantation (FMT)+1 more
Central Jutland Regional Hospital16 enrolled1 locationNCT07375797
Recruiting

Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction

Exercise TrainingHFrEF - Heart Failure With Reduced Ejection FractionCardiac Rehabilitation+3 more
Centre Hospitalier de Corbie62 enrolled1 locationNCT07164911
Recruiting
Phase 1

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

Chronic Kidney DiseasesEnd-stage Kidney DiseaseImmunological Tolerance+1 more
University of California, Los Angeles10 enrolled1 locationNCT05525507
Recruiting
Not Applicable

Test of Target Engagement of Ambiguity Aversion

Depression, AnxietyAnxietyIntolerance of Uncertainty+1 more
Northwestern University140 enrolled1 locationNCT06962527
Recruiting
Phase 1Phase 2

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

Platinum Resistant Ovarian CancerPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
TILT Biotherapeutics Ltd.29 enrolled3 locationsNCT05271318
Recruiting
Not Applicable

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Diabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio700 enrolled1 locationNCT02969798
Recruiting
Not Applicable

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

Arterial StiffnessBody CompositionAdult+9 more
Georgia State University30 enrolled1 locationNCT06735651
Recruiting
Early Phase 1

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

Diabetes Mellitus, Type 2Impaired Glucose Tolerance
Tongji Hospital84 enrolled1 locationNCT06964620
Recruiting
Phase 2

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Not Applicable

The Acute T-Rex (Timing of Resistance Exercise) Study

Insulin ResistanceDiabetes Mellitus, Type 2Sleep Disturbance+3 more
University of Utah20 enrolled1 locationNCT06366399
Recruiting
Phase 4

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Liver FibrosisGlycemic ControlLiver Fat+3 more
Getz Pharma164 enrolled1 locationNCT05644717
Recruiting
Not Applicable

Peanuts for Cardiometabolic, Brain, and Intestinal Health

AdultPrediabetesCognition+5 more
Georgia State University72 enrolled1 locationNCT06867198
Recruiting
Early Phase 1

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Safety IssuesTolerance
Kariya Pharmaceuticals88 enrolled1 locationNCT06189170
Recruiting
Phase 3

Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes

Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven252 enrolled13 locationsNCT05569772
Recruiting
Not Applicable

Antidiabetic Effect of Olive Pomace Oil

Diabetes MellitusDiabetesType 2 Diabetes Mellitus+2 more
Instituto de Ciencia y Tecnología de Alimentos y Nutrición50 enrolled1 locationNCT06723886
Recruiting
Not Applicable

ESAN II - Energy Sensing in Depression

ObesityDiet, HealthyDepression+2 more
Medical University of Graz120 enrolled1 locationNCT05432362
Recruiting

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes Mellitus+1 more
Aarhus University Hospital100 enrolled1 locationNCT05873322
Recruiting
Not Applicable

Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease

Quality of LifeInflammatory Bowel DiseasesCrohn Disease+3 more
Lebanese University50 enrolled1 locationNCT06392061
Recruiting
Not Applicable

Dietary Strategies for Remission of Type 2 Diabetes

Insulin ResistanceHypertensionDiabetes Mellitus, Type 2+3 more
University of Bergen600 enrolled1 locationNCT04943926